256 related articles for article (PubMed ID: 20541026)
41. KIR genes and KIR ligands affect occurrence of acute GVHD after unrelated, 12/12 HLA matched, hematopoietic stem cell transplantation.
Ludajic K; Balavarca Y; Bickeböller H; Rosenmayr A; Fae I; Fischer GF; Kouba M; Pohlreich D; Kalhs P; Greinix HT
Bone Marrow Transplant; 2009 Jul; 44(2):97-103. PubMed ID: 19169284
[TBL] [Abstract][Full Text] [Related]
42. Tumour necrosis factor receptor type II 196M/R genotype correlates with circulating soluble receptor levels in normal subjects and with graft-versus-host disease after sibling allogeneic bone marrow transplantation.
Stark GL; Dickinson AM; Jackson GH; Taylor PR; Proctor SJ; Middleton PG
Transplantation; 2003 Dec; 76(12):1742-9. PubMed ID: 14688526
[TBL] [Abstract][Full Text] [Related]
43. Association of HMGB1 polymorphisms with outcome after allogeneic hematopoietic cell transplantation.
Kornblit B; Masmas T; Petersen SL; Madsen HO; Heilmann C; Schejbel L; Sengeløv H; Müller K; Garred P; Vindeløv L
Biol Blood Marrow Transplant; 2010 Feb; 16(2):239-52. PubMed ID: 19819342
[TBL] [Abstract][Full Text] [Related]
44. HLA Association with hematopoietic stem cell transplantation outcome: the number of mismatches at HLA-A, -B, -C, -DRB1, or -DQB1 is strongly associated with overall survival.
Loiseau P; Busson M; Balere ML; Dormoy A; Bignon JD; Gagne K; Gebuhrer L; Dubois V; Jollet I; Bois M; Perrier P; Masson D; Moine A; Absi L; Reviron D; Lepage V; Tamouza R; Toubert A; Marry E; Chir Z; Jouet JP; Blaise D; Charron D; Raffoux C
Biol Blood Marrow Transplant; 2007 Aug; 13(8):965-74. PubMed ID: 17640601
[TBL] [Abstract][Full Text] [Related]
45. Risk-factor analysis for predicting progressive- or quiescent-type chronic graft-versus-host disease in a patient cohort with a history of acute graft-versus-host disease after allogeneic stem cell transplantation.
Sohn SK; Kim DH; Baek JH; Kim JG; Lee KB; Lee KH; Lee JH; Choi SJ; Lee JH; Shin IH
Bone Marrow Transplant; 2006 Apr; 37(7):699-708. PubMed ID: 16501588
[TBL] [Abstract][Full Text] [Related]
46. Functional polymorphism of CTLA-4 and ICOS genes in allogeneic hematopoietic stem cell transplantation.
Wu J; Tang JL; Wu SJ; Lio HY; Yang YC
Clin Chim Acta; 2009 May; 403(1-2):229-33. PubMed ID: 19332044
[TBL] [Abstract][Full Text] [Related]
47. Clinical significance of HLA-E*0103 homozygosity on survival after allogeneic hematopoietic stem-cell transplantation.
Danzer M; Polin H; Pröll J; Haunschmid R; Hofer K; Stabentheiner S; Hackl C; Kasparu H; König J; Hauser H; Binder M; Weiss R; Gabriel C; Krieger O
Transplantation; 2009 Aug; 88(4):528-32. PubMed ID: 19696636
[TBL] [Abstract][Full Text] [Related]
48. Vitamin D receptor gene polymorphism associates with graft-versus-host disease and survival in HLA-matched sibling allogeneic bone marrow transplantation.
Middleton PG; Cullup H; Dickinson AM; Norden J; Jackson GH; Taylor PR; Cavet J
Bone Marrow Transplant; 2002 Aug; 30(4):223-8. PubMed ID: 12203138
[TBL] [Abstract][Full Text] [Related]
49. Impact of cyclosporine-A concentration on the incidence of severe acute graft-versus-host disease after allogeneic stem cell transplantation.
Malard F; Szydlo RM; Brissot E; Chevallier P; Guillaume T; Delaunay J; Ayari S; Dubruille V; Le Gouill S; Mahe B; Gastinne T; Blin N; Saulquin B; Harousseau JL; Moreau P; Mohty M
Biol Blood Marrow Transplant; 2010 Jan; 16(1):28-34. PubMed ID: 20053329
[TBL] [Abstract][Full Text] [Related]
50. Preengraftment serum C-reactive protein (CRP) value may predict acute graft-versus-host disease and nonrelapse mortality after allogeneic hematopoietic stem cell transplantation.
Fuji S; Kim SW; Fukuda T; Mori S; Yamasaki S; Morita-Hoshi Y; Ohara-Waki F; Heike Y; Tobinai K; Tanosaki R; Takaue Y
Biol Blood Marrow Transplant; 2008 May; 14(5):510-7. PubMed ID: 18410893
[TBL] [Abstract][Full Text] [Related]
51. Insufficient evidence for association of NOD2/CARD15 or other inflammatory bowel disease-associated markers on GVHD incidence or other adverse outcomes in T-replete, unrelated donor transplantation.
Nguyen Y; Al-Lehibi A; Gorbe E; Li E; Haagenson M; Wang T; Spellman S; Lee SJ; Davidson NO
Blood; 2010 Apr; 115(17):3625-31. PubMed ID: 20177049
[TBL] [Abstract][Full Text] [Related]
52. Standard versus alternative myeloablative conditioning regimens in allogeneic hematopoietic stem cell transplantation for high-risk acute leukemia.
Mengarelli A; Iori A; Guglielmi C; Romano A; Cerretti R; Torromeo C; Micozzi A; Fenu S; Laurenti L; Donato V; De Felice L; Arcese W
Haematologica; 2002 Jan; 87(1):52-8. PubMed ID: 11801465
[TBL] [Abstract][Full Text] [Related]
53. Polymorphisms of transforming growth factor-beta1 and transforming growth factor-beta1 type II receptor genes are associated with acute graft-versus-host disease in children with HLA-matched sibling bone marrow transplantation.
Hattori H; Matsuzaki A; Suminoe A; Ihara K; Nagatoshi Y; Sakata N; Kawa K; Okamura J; Hara T
Bone Marrow Transplant; 2002 Nov; 30(10):665-71. PubMed ID: 12420205
[TBL] [Abstract][Full Text] [Related]
54. The impact of KIR2DS4 alleles and the expression of KIR in the development of acute GVHD after unrelated allogeneic hematopoietic SCT.
Bao XJ; Hou LH; Sun AN; Qiu QC; Yuan XN; Chen MH; Chen ZX; He J
Bone Marrow Transplant; 2010 Sep; 45(9):1435-41. PubMed ID: 20062104
[TBL] [Abstract][Full Text] [Related]
55. Interleukin 12 is associated with reduced relapse without increased incidence of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
Reddy V; Winer AG; Eksioglu E; Meier-Kriesche HU; Schold JD; Wingard JR
Biol Blood Marrow Transplant; 2005 Dec; 11(12):1014-21. PubMed ID: 16338624
[TBL] [Abstract][Full Text] [Related]
56. Higher CD34(+) and CD3(+) cell doses in the graft promote long-term survival, and have no impact on the incidence of severe acute or chronic graft-versus-host disease after in vivo T cell-depleted unrelated donor hematopoietic stem cell transplantation in children.
Kałwak K; Porwolik J; Mielcarek M; Gorczyńska E; Owoc-Lempach J; Ussowicz M; Dyla A; Musiał J; Paździor D; Turkiewicz D; Chybicka A
Biol Blood Marrow Transplant; 2010 Oct; 16(10):1388-401. PubMed ID: 20382248
[TBL] [Abstract][Full Text] [Related]
57. Cotransplantation of mesenchymal stem cells might prevent death from graft-versus-host disease (GVHD) without abrogating graft-versus-tumor effects after HLA-mismatched allogeneic transplantation following nonmyeloablative conditioning.
Baron F; Lechanteur C; Willems E; Bruck F; Baudoux E; Seidel L; Vanbellinghen JF; Hafraoui K; Lejeune M; Gothot A; Fillet G; Beguin Y
Biol Blood Marrow Transplant; 2010 Jun; 16(6):838-47. PubMed ID: 20109568
[TBL] [Abstract][Full Text] [Related]
58. CCR5 deletion mutation and its association with the risk of developing acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
Bogunia-Kubik K; Duda D; Suchnicki K; Lange A
Haematologica; 2006 Dec; 91(12):1628-34. PubMed ID: 17145599
[TBL] [Abstract][Full Text] [Related]
59. Donor single nucleotide polymorphism in the CCR9 gene affects the incidence of skin GVHD.
Inamoto Y; Murata M; Katsumi A; Kuwatsuka Y; Tsujimura A; Ishikawa Y; Sugimoto K; Onizuka M; Terakura S; Nishida T; Kanie T; Taji H; Iida H; Suzuki R; Abe A; Kiyoi H; Matsushita T; Miyamura K; Kodera Y; Naoe T
Bone Marrow Transplant; 2010 Feb; 45(2):363-9. PubMed ID: 19525985
[TBL] [Abstract][Full Text] [Related]
60. Protective role of interleukin-10 promoter gene polymorphism in the pathogenesis of invasive pulmonary aspergillosis after allogeneic stem cell transplantation.
Seo KW; Kim DH; Sohn SK; Lee NY; Chang HH; Kim SW; Jeon SB; Baek JH; Kim JG; Suh JS; Lee KB
Bone Marrow Transplant; 2005 Dec; 36(12):1089-95. PubMed ID: 16247433
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]